Max Little, Charlotte Binnie, Derek Effiom, Jonathan Super, Iris Kwok, Peter Rosenfeld
{"title":"The Salto Mobile-Bearing Total Ankle Arthroplasty: Survivorship, Radiologic, and Clinical Outcomes at an Average 9-Year Follow-Up.","authors":"Max Little, Charlotte Binnie, Derek Effiom, Jonathan Super, Iris Kwok, Peter Rosenfeld","doi":"10.1177/10711007251322147","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Total ankle arthroplasty (TAA) remains an excellent treatment option for end-stage ankle osteoarthritis. Questions remain regarding the superiority of either fixed- or mobile-bearing implants because of equipoise in the literature and a paucity of long-term follow-up. We present results of the Salto mobile-bearing TAA, aiming to add to the literature for longer-term follow-up of this mobile-bearing TAA and investigate the survivorship and patient satisfaction with this implant.</p><p><strong>Methods: </strong>TAA was performed in 91 consecutive ankles (87 patients) in an independent, prospective, single-surgeon study. The minimum follow-up was set at 5 years. Implant survival, patient-reported outcome measures (PROMs), and radiographic outcomes are presented at a mean of 9.1 years (range 5-18 years).</p><p><strong>Results: </strong>Nine ankles (9 patients) were lost to follow-up or were unable to comply. Eighty-two ankles (78 patients) were included with a mean age of 69.5 years at the time of their operation. Six of 82 ankles (7.3%) underwent revision of any of the components. Four were revisions involving the metallic components to fusion or revision TAA, all within 5 years of the index procedure. Three ankles (3.7%) underwent reoperations. With all-cause revision of any component (including the polyethylene liner) as an endpoint, implant survival was calculated using Kaplan-Meier curves as 95.0% at 5 years and 93.2% at 10 years. Reported PROMs were very high and we found no progressive linear lucencies, cysts, or subsidence in TAAs other than in those that underwent revision or reoperation.</p><p><strong>Conclusion: </strong>Our study of 82 Salto mobile-bearing TAAs found commendable survivorship, along with robust radiographic and patient-reported outcomes at an average of 9 years, with survivorship rates comparable to those reported for fixed-bearing implants.</p>","PeriodicalId":94011,"journal":{"name":"Foot & ankle international","volume":" ","pages":"10711007251322147"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Foot & ankle international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10711007251322147","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Total ankle arthroplasty (TAA) remains an excellent treatment option for end-stage ankle osteoarthritis. Questions remain regarding the superiority of either fixed- or mobile-bearing implants because of equipoise in the literature and a paucity of long-term follow-up. We present results of the Salto mobile-bearing TAA, aiming to add to the literature for longer-term follow-up of this mobile-bearing TAA and investigate the survivorship and patient satisfaction with this implant.
Methods: TAA was performed in 91 consecutive ankles (87 patients) in an independent, prospective, single-surgeon study. The minimum follow-up was set at 5 years. Implant survival, patient-reported outcome measures (PROMs), and radiographic outcomes are presented at a mean of 9.1 years (range 5-18 years).
Results: Nine ankles (9 patients) were lost to follow-up or were unable to comply. Eighty-two ankles (78 patients) were included with a mean age of 69.5 years at the time of their operation. Six of 82 ankles (7.3%) underwent revision of any of the components. Four were revisions involving the metallic components to fusion or revision TAA, all within 5 years of the index procedure. Three ankles (3.7%) underwent reoperations. With all-cause revision of any component (including the polyethylene liner) as an endpoint, implant survival was calculated using Kaplan-Meier curves as 95.0% at 5 years and 93.2% at 10 years. Reported PROMs were very high and we found no progressive linear lucencies, cysts, or subsidence in TAAs other than in those that underwent revision or reoperation.
Conclusion: Our study of 82 Salto mobile-bearing TAAs found commendable survivorship, along with robust radiographic and patient-reported outcomes at an average of 9 years, with survivorship rates comparable to those reported for fixed-bearing implants.